Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy
- PMID: 28249134
- PMCID: PMC5605129
- DOI: 10.1056/NEJMoa1606205
Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy
Abstract
Background: Subclinical thyroid disease during pregnancy may be associated with adverse outcomes, including a lower-than-normal IQ in offspring. It is unknown whether levothyroxine treatment of women who are identified as having subclinical hypothyroidism or hypothyroxinemia during pregnancy improves cognitive function in their children.
Methods: We screened women with a singleton pregnancy before 20 weeks of gestation for subclinical hypothyroidism, defined as a thyrotropin level of 4.00 mU or more per liter and a normal free thyroxine (T4) level (0.86 to 1.90 ng per deciliter [11 to 24 pmol per liter]), and for hypothyroxinemia, defined as a normal thyrotropin level (0.08 to 3.99 mU per liter) and a low free T4 level (<0.86 ng per deciliter). In separate trials for the two conditions, women were randomly assigned to receive levothyroxine or placebo. Thyroid function was assessed monthly, and the levothyroxine dose was adjusted to attain a normal thyrotropin or free T4 level (depending on the trial), with sham adjustments for placebo. Children underwent annual developmental and behavioral testing for 5 years. The primary outcome was the IQ score at 5 years of age (or at 3 years of age if the 5-year examination was missing) or death at an age of less than 3 years.
Results: A total of 677 women with subclinical hypothyroidism underwent randomization at a mean of 16.7 weeks of gestation, and 526 with hypothyroxinemia at a mean of 17.8 weeks of gestation. In the subclinical hypothyroidism trial, the median IQ score of the children was 97 (95% confidence interval [CI], 94 to 99) in the levothyroxine group and 94 (95% CI, 92 to 96) in the placebo group (P=0.71). In the hypothyroxinemia trial, the median IQ score was 94 (95% CI, 91 to 95) in the levothyroxine group and 91 (95% CI, 89 to 93) in the placebo group (P=0.30). In each trial, IQ scores were missing for 4% of the children. There were no significant between-group differences in either trial in any other neurocognitive or pregnancy outcomes or in the incidence of adverse events, which was low in both groups.
Conclusions: Treatment for subclinical hypothyroidism or hypothyroxinemia beginning between 8 and 20 weeks of gestation did not result in significantly better cognitive outcomes in children through 5 years of age than no treatment for those conditions. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke; ClinicalTrials.gov number, NCT00388297 .).
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Comment in
-
Subclinical Hypothyroidism and Hypothyroxinemia in Pregnancy - Still No Answers.N Engl J Med. 2017 Mar 2;376(9):876-877. doi: 10.1056/NEJMe1615312. N Engl J Med. 2017. PMID: 28249140 No abstract available.
-
L-Thyroxin für viele Schwangere kein Muss?MMW Fortschr Med. 2017 May;159(9):40. doi: 10.1007/s15006-017-9641-2. MMW Fortschr Med. 2017. PMID: 28509025 German. No abstract available.
-
Skal subklinisk hypotyreose i graviditeten behandles?Ugeskr Laeger. 2017 May 29;179(22):V69190. Ugeskr Laeger. 2017. PMID: 28553919 Danish. No abstract available.
-
Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy.N Engl J Med. 2017 Aug 17;377(7):700. doi: 10.1056/NEJMc1707415. N Engl J Med. 2017. PMID: 28813222 No abstract available.
-
Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy.N Engl J Med. 2017 Aug 17;377(7):700-1. doi: 10.1056/NEJMc1707415. N Engl J Med. 2017. PMID: 28816427 No abstract available.
Similar articles
-
Association of Mild Iodine Insufficiency during Pregnancy with Child Neurodevelopment in Patients with Subclinical Hypothyroidism or Hypothyroxinemia.Am J Perinatol. 2024 May;41(S 01):e3326-e3332. doi: 10.1055/s-0043-1778037. Epub 2024 Jan 16. Am J Perinatol. 2024. PMID: 38228158 Clinical Trial.
-
Antenatal thyroid screening and childhood cognitive function.N Engl J Med. 2012 Feb 9;366(6):493-501. doi: 10.1056/NEJMoa1106104. N Engl J Med. 2012. PMID: 22316443 Free PMC article. Clinical Trial.
-
Subclinical hypothyroidism in pregnancy: intellectual development of offspring.Thyroid. 2011 Oct;21(10):1143-7. doi: 10.1089/thy.2011.0053. Thyroid. 2011. PMID: 21943136 Free PMC article.
-
Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health.Cochrane Database Syst Rev. 2015 Sep 21;2015(9):CD011263. doi: 10.1002/14651858.CD011263.pub2. Cochrane Database Syst Rev. 2015. PMID: 26387772 Free PMC article. Review.
-
Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?J Clin Endocrinol Metab. 2000 Nov;85(11):3975-87. doi: 10.1210/jcem.85.11.6961. J Clin Endocrinol Metab. 2000. PMID: 11095417 Review.
Cited by
-
Evaluating the progression to abnormal thyrotropin in euthyroid preconception women: a population-based study.Thyroid Res. 2024 Mar 11;17(1):5. doi: 10.1186/s13044-024-00192-w. Thyroid Res. 2024. PMID: 38462616 Free PMC article.
-
Risks of suboptimal and excessive thyroid hormone replacement across ages.J Endocrinol Invest. 2024 May;47(5):1083-1090. doi: 10.1007/s40618-023-02229-7. Epub 2023 Nov 28. J Endocrinol Invest. 2024. PMID: 38015369 Free PMC article. Review.
-
Association between inadequate weight gain according to the institute of medicine 2009 guidelines and pregnancy outcomes in women with thyroid disorders.Arch Gynecol Obstet. 2024 Aug;310(2):961-969. doi: 10.1007/s00404-023-07279-z. Epub 2023 Nov 19. Arch Gynecol Obstet. 2024. PMID: 37981602
-
Maternal thyroid hormone receptor β activation in mice sparks brown fat thermogenesis in the offspring.Nat Commun. 2023 Oct 24;14(1):6742. doi: 10.1038/s41467-023-42425-w. Nat Commun. 2023. PMID: 37875497 Free PMC article.
-
In infertile women with subclinical hypothyroidism, with or without thyroid peroxidase antibodies, serum TSH during pregnancy follows preconception values and thyroid hormones remain stable.Hum Reprod Open. 2023 Oct 9;2023(4):hoad038. doi: 10.1093/hropen/hoad038. eCollection 2023. Hum Reprod Open. 2023. PMID: 37869413 Free PMC article.
References
-
- Davis LE, Leveno KJ, Cunningham FG. Hypothyroidism complicating pregnancy. Obstet Gynecol. 1988;72:108–12. - PubMed
-
- Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol. 1993;81:349–53. - PubMed
-
- Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12:63–8. - PubMed
-
- Männistö T, Vääräsmäki M, Pouta A, et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab. 2009;94:772–9. - PubMed
-
- Su PY, Huang K, Hao JH, et al. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab. 2011;96:3234–41. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- U10 HD053118/HD/NICHD NIH HHS/United States
- U10 HD040500/HD/NICHD NIH HHS/United States
- UG1 HD027869/HD/NICHD NIH HHS/United States
- U10 HD040544/HD/NICHD NIH HHS/United States
- UG1 HD034116/HD/NICHD NIH HHS/United States
- UG1 HD040560/HD/NICHD NIH HHS/United States
- UG1 HD087230/HD/NICHD NIH HHS/United States
- UG1 HD053097/HD/NICHD NIH HHS/United States
- UG1 HD027915/HD/NICHD NIH HHS/United States
- U10 HD040485/HD/NICHD NIH HHS/United States
- U10 HD034116/HD/NICHD NIH HHS/United States
- U10 HD027869/HD/NICHD NIH HHS/United States
- U10 HD027917/HD/NICHD NIH HHS/United States
- UG1 HD040485/HD/NICHD NIH HHS/United States
- U10 HD040560/HD/NICHD NIH HHS/United States
- UG1 HD040500/HD/NICHD NIH HHS/United States
- U10 HD040512/HD/NICHD NIH HHS/United States
- U10 HD040545/HD/NICHD NIH HHS/United States
- U01 HD036801/HD/NICHD NIH HHS/United States
- UG1 HD040544/HD/NICHD NIH HHS/United States
- UG1 HD034208/HD/NICHD NIH HHS/United States
- UG1 HD040512/HD/NICHD NIH HHS/United States
- U10 HD027915/HD/NICHD NIH HHS/United States
- UG1 HD040545/HD/NICHD NIH HHS/United States
- U10 HD034208/HD/NICHD NIH HHS/United States
- U10 HD053097/HD/NICHD NIH HHS/United States
- U10 HD021410/HD/NICHD NIH HHS/United States
- U10 HD036801/HD/NICHD NIH HHS/United States
- U24 HD036801/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials